XJ, F., C, M., L, G., & LE, L. (2025). Therapeutic efficacy of rituximab combined with cyclosporin A on B-cell dysregulation in chronic graft-versus-host disease. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 27(4), 1789. https://doi.org/10.1007/s12094-024-03684-1
Chicago Style (17th ed.) CitationXJ, Fu, Meng C, Guo L, and Lin LE. "Therapeutic Efficacy of Rituximab Combined with Cyclosporin A on B-cell Dysregulation in Chronic Graft-versus-host Disease." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 27, no. 4 (2025): 1789. https://doi.org/10.1007/s12094-024-03684-1.
MLA (9th ed.) CitationXJ, Fu, et al. "Therapeutic Efficacy of Rituximab Combined with Cyclosporin A on B-cell Dysregulation in Chronic Graft-versus-host Disease." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 27, no. 4, 2025, p. 1789, https://doi.org/10.1007/s12094-024-03684-1.